Thursday, January 11, 2008

Obtaining a Posititon

12:30 pm - 1:30 pm

• Evaluating the Opportunity—David P. Foley, MD
• Negotiation—Seth J. Karp, MD

Relationship with your Institution and Career Advancement

1:30 pm - 3:15 pm

• Establishing Yourself Clinically—Ronald M. Ferguson, MD, PhD
• Academic Productivity—John P. Roberts, MD
• Managing Your Time and Creating Margin—Douglas W. Hanto, MD, PhD

Running a Practice

3:15 pm - 5:00 pm

• Building and Maintaining a Referral Base—Thomas G. Peters, MD
• Financial Consideration—Michael M. Abecassis, MD, MBA
• Who Wants to be a Millionaire: Reducing your Risk of Medical Malpractice—Cliff Rapp, LHRM

Friday, January 12, 2008

Running a Clinical Research Program

7:30 am - 8:30 am

• Nuts and Bolts of Runing a Clinical Research/Outcomes Program—Robert M. Merion, MD
• How to Run A Clinical Trial—David A. Gerber, MD

Managing a Clinical Transplant Program

8:30 am - 12:00 pm

• Managing Your Program Operations—Ravi S. Chari, MD
• Managing Your Patients—James J. Wynn, MD
• What Data is Collected and How it is Used—John C. Magee, MD
• Is My Program in Trouble? How Increased Scrutiny Affects My Practice—Timothy L. Pruett, MD
• Managing Your Peers—Goran B. Klintmalm, MD, PhD, FACS

Friday, January 12, 2008

Defining the High Risk Recipient

12:00pm - 2:25pm

• Give Me Your Tired, Your Poor: Framing the Problem—Thomas G. Peters, MD
• Yesterday When I was Young: The Changing High Risk Recipient—John P. Roberts, MD
• Turn the Beat Around: The Impact of Coronary Artery Disease on Transplant Outcomes—George Tellides, MD, PhD
• Mellow Yellow in a Non-Liver Fellow: Hepatitis C in the Extrahepatic Recipient—Timothy L. Pruett, MD
• The Dog Ate My Pills: Potential Psychosocial Risk Factors—Cheryl Jacobs, LICSW
• What's In It for Me: Defining Transplant Benefit—Robert A. Wolfe, PhD

Keynote Speaker Session

2:25 pm - 4:00 pm

• Road to Nowhere: Are There Patients That Should Not Be Transplanted? Pro—Mark D. Stegall, MD
• Road to Nowhere: Are There Patients That Should Not Be Transplanted? Con—Goran B. Klintmalm, MD, PhD, FACS

Saturday, January 13, 2008

How Do You Make the Bad Not So Bad

8:00 am – 9:30 am

• Honey, You Shrunk My Tumor: Downstaging for HCC—Francis Y. Yao, MD
• Under Pressure: Pulmonary Hypertension In Heart Transplant Recipients—Abbas Ardehali, MD
• Papa’s Got a Brand New Bag: Gastric Bypass and Transplantation—J. Wesley Alexander, MD, ScD
• You Can't Always get What You Want: The Right Organ for the Right Recipient—Sandy Feng, MD, PhD

Oral Abstract Presentations

9:45 am – 11:05 am

• Maintenance of Allograft Function May Reduce the Risk of Cerebrovascular Disease Events after Kidney Transplantation—Krista L. Lentine, MD, MS
• Gender Disparities in Access to Transplantation for Elderly Patients—Dorry Segev, MD
• A Comparison of Living Donor and Deceased Donor Liver Transplantation for Hilar Cholangiocarcinoma—H.S. Pollinger, DO
• Combined Liver-Kidney and Liver Transplantation in Patients with Renal Failure Outcomes in the Meld Era—Timothy M. Schmitt, MD
• Declining Outcomes in Simultaneous Liver Kidney Transplantation in the MELD Era Ineffective Utilization of Renal Allografts—Jayme E. Locke, MD, MPH
• The Outcome of Heart Transplant Recipients Bridged with Combined Mechanical Cardiorenal Support—Aleck Stockins, MD
• Do High MELD Recipients of ECD's Have Worse Patient or Graft Survival Than Similar Recipients of Standard Donors (SD)? A Single Center 5-Year Report among 628 Adult Cadaveric Liver Recipients —Kambiz Kosari, MD

The Surgically Challenging Recipient

11:20 am – 12:20 pm

• Heart of My heart: Repair vs. Transplantation for Congenital Heart Disease —Peter J. Gruber, MD, PhD
• No Guts, No Glory: Challenges in the Intestinal Transplant Recipient—Wendy J. Grant, MD
• Up the Lazy River: Kidney/Pancreas in Recipients with Aortoiliac Disease—Clarence E. Foster, III, MD

Sunday, January 13, 2008

Debates

11:00 am – 12:20 pm

• Pediatric Kidney Live Donors vs. Deceased Donors for Primary Transplant- Pro—H. Albin Gritsch, MD
• Pediatric Kidney Live Donors vs. Deceased Donors for Primary Transplant- Con—Kenneth A. Andreoni, MD
• Won't Get Fooled Again: Liver Retransplantation for Hepatitis C - Pro—R. Mark Ghobrial, MD, PhD
• Won't Get Fooled Again: Liver Retransplantation for Hepatitis C - Con—Alan N. Langnas, DO
• Risky Business: Should Transplant Outcomes be Risk Adjusted - Pro—Mark A. Schnitzler, PhD
• Risky Business: Should Transplant Outcomes be Risk Adjusted - Con—Roger W. Evans, PhD

Friday, January 12, 2008

Medicare 101: What every Transplant Surgeon Must Know

7:30 am - 12:00 pm

• Cost accounting: You are not an accountant, but you need to know this—Paul Kuo, MD, MBA
• ABCs of Transplantation: Names and acronyms in the world of transplantation—Marwan S. Abouljoud, MD
• Introduction to Medicare: Rationale and Expectations—Richard B. Freeman, MD
• Components of the acquisition cost center: What can you bill for?—Rebecca Burke, Esq. and Diane Millman, Esq.
• Impact of Medicare Acquisition on your professional practice: More Money?—Micheal Abecassis, MD, MBA
• Capturing the Revenue: Personal Experience—Dinesh Ranjan, MD